LOGO
LOGO

Quick Facts

UTHealth Gets FDA Approval To Market Coronary FlowReserve QuantificationSoftware

By RTTNews Staff Writer   ✉  | Published:  | Google News Follow Us  | Join Us
rttnewslogo20mar2024

Positron Corp. (POSC.OB) announced the FDA's marketing approval of The University of Texas Health Science Center at Houston or UTHealth Coronary Flow Reserve or CFR quantification software, cfrQuant.

The company stated that the cfrQuant software was developed under the guidance of Lance Gould, and the Weatherhead PET Imaging Center of the UTHealth Medical School, with contributions of software segments from Positron Corporation.

Positron said it will distribute and support cfrQuant to its current and future U.S. based cardiac PET customers, under a licensing agreement with UTHealth. The cfrQuant software has been approved for use with 82Rb-chloride and 13N-ammonia. Gould has recused himself of receiving royalties in support of academic programs.

For comments and feedback contact: editorial@rttnews.com

Business News

Global Economics Weekly Update - Jun 01 - Jun 05, 2026

June 05, 2026 16:18 ET
A busy week for economic news flow saw a slew of reports being released that reflected the trends in the U.S. labor market. In Europe, economic growth and inflation data gained attention as the European Central Bank and Bank of England head for policy session later in the month. In Asia, the monetary policy session of the Indian central bank was in focus as the country, a major oil importer, reels under the pressures of a weaker rupee and rising inflation.

Latest Updates on COVID-19